Adeoye Y. Olukotun is Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR). They have made 5 open-market trades across 2 companies since 2020, most recently 2026-08-18.
CIK 0001242615
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $5K since 2020, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ARWR | 31,600 | $1.8M |
| TNXP | 5,350 | $32K |
| DDXS | 5,958 | — |
| ICGN | 7,062 | — |
| VIAP | 59,624 | — |
| Total | $1.8M |
Shares reported on the most recent Form 4, priced at the 2026-08-20 close. 3 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ARWR | SELL | 2026-08-18 | 2026-08-20 | $86.96 | $174K | -6.0% | -21.8% | — |
| ARWR | SELL · 10b5-1 | 2025-12-19 | 2025-12-23 | $67.84 | $1.1M | +3.4% | +1.6% | -17.2% |
| ARWR | SELL · 10b5-1 | 2025-01-23 | 2025-01-27 | $21.00 | $20K | +0.4% | -5.7% | -33.7% |
| ARWR | SELL · 10b5-1 | 2024-12-27 | 2024-12-30 | $20.00 | $57K | +0.7% | +6.2% | -32.2% |
| ARWR | SELL | 2023-03-03 | 2023-03-06 | $32.65 | $741K | -20.2% | -17.5% | +14.3% |
| ARWR | SELL | 2022-01-03 | 2022-01-04 | $64.70 | $508K | -10.2% | -23.9% | -21.4% |
| ARWR | SELL | 2021-09-13 | 2021-09-14 | $63.76 | $319K | +4.7% | +7.0% | +14.4% |
| TNXP | BUY | 2020-08-13 | 2020-08-17 | $0.94 | $5K | -4.8% | -13.9% | -40.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.